Status:
COMPLETED
Effects of Myo-inositol in Women With Polycystic Ovary Syndrome
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Polycystic Ovary Syndrome
Resistance, Insulin
Eligibility:
FEMALE
19-36 years
Phase:
NA
Brief Summary
The study will be carried out at the hospital of the medical school of sao paulo (HC-FMUSP) and the goal is to compare the effects of the administration of myo-inositol in relation to the effects of m...
Detailed Description
The study will involve 60 women in the reproductive period, with a variable between 19 and 36 years old and diagnosed with polycystic ovary syndrome (PCOS), according to Rotterdam- European Society of...
Eligibility Criteria
Inclusion
- Women aged 19 to 36 with diagnosis of PCOS and insulin resistance or glucose intolerance.
Exclusion
- Previous use of any hormonal treatment in the past three months;
- Other causes of anovulation;
- Gynecological or other associated conditions (endometriosis, adenomyosis or diabetes mellitus);
- FSH (Follicle Stimulating Hormone) \> 15 Ul / L (2nd to 5th day of the cycle);
- Beta-hcG (human chorionic gonadotropin) positive (pregnancy).
Key Trial Info
Start Date :
March 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04892186
Start Date
March 26 2021
End Date
October 20 2023
Last Update
February 20 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Das Clinicas - Fmusp
São Paulo, Brazil, 05403000
2
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, Brazil, 05403000